A Single-Center, Open-Label, Randomized, Two-Stage, Two-Way Crossover Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Rifampin Capsules in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 05 Aug 2019
Price : $35 *
At a glance
- Drugs HSK 3486 (Primary) ; Rifampicin
- Indications Anaesthesia
- Focus Pharmacokinetics
- Sponsors Sichuan Haisco Pharmaceutical
- 31 Jul 2019 Status changed from not yet recruiting to completed.
- 21 Feb 2019 Planned initiation date changed from 30 Jan 2019 to 30 Mar 2019.
- 09 Jan 2019 Planned primary completion date changed from 1 Jan 2019 to 1 Apr 2019.